Program Note: This is for informational purposes only, and NYSE does not recommend any investments or investment strategies.

Join theCUBE + NYSE Wired at the New York Stock Exchange as healthcare and life sciences leaders confront a familiar MedTech reality: Innovation is abundant, but only a fraction of new tools survive regulation, clinical scrutiny and day-to-day care delivery. This series focuses on how device makers, providers and their partners are turning digital capability into operational practice — improving outcomes, easing bottlenecks and reducing clinician burden without sacrificing trust, privacy or accountability.

Our coverage examines where AI and digital systems actually create value once they meet clinical workflows, reimbursement models and regulatory oversight. The emphasis is on execution over experimentation: evidence, integration and who ultimately captures value when healthcare workflows finally change.